Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blue Jet HealthcareBOM:544009 +1.74%62 Shareholder Yield % is 0.02% as of Mar. 2026, which is 60% below its 10-year median of 0.05. GuruFocus rates BOM:544009 with a GF Score™ of 62/100 and a GF Value™ of ₹566.03 (Fairly Valued). The stock has 10 warning signs investors should review. Among 1,296 Biotechnology companies, Blue Jet Healthcare ranks better than 64.89% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Blue Jet Healthcare's Shareholder Yield % was 0.02%.
Blue Jet Healthcare (BOM:544009) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Blue Jet Healthcare Shareholder Yield % Related Terms
Blue Jet Healthcare Shareholder Yield % Historical Data
* Premium members only.
The historical data trend for Blue Jet Healthcare's Shareholder Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544009 vs VRTX, REGN, RVMD: Shareholder Yield % Comparison
For the Biotechnology subindustry, Blue Jet Healthcare's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blue Jet Healthcare Shareholder Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Blue Jet Healthcare's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Blue Jet Healthcare (BOM:544009) has a Shareholder Yield % of 0.02% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Blue Jet Healthcare and its competitors. This is 60% below median its historical median of 0.05. Over the past decade, Blue Jet Healthcare's Shareholder Yield % has ranged from 0.02 to 0.22. According to the industry distribution chart, Blue Jet Healthcare ranks #455 out of 1296 companies in the Biotechnology industry, placing it in the top 35.1%.
Is Blue Jet Healthcare's Shareholder Yield % too high?
Blue Jet Healthcare's current Shareholder Yield % of 0.02% is 60% below median its 10-year median of 0.05. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.22. Based on the distribution chart, Blue Jet Healthcare ranks #455 out of 1296 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Blue Jet Healthcare has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Blue Jet Healthcare's Shareholder Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Blue Jet Healthcare ranks #455 out of 1296 companies for Shareholder Yield %. This puts Blue Jet Healthcare in the upper half of its industry. Historically, Blue Jet Healthcare's own Shareholder Yield % has ranged from 0.02 to 0.22 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Biotechnology company?
A good Shareholder Yield % depends on the Biotechnology industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Blue Jet Healthcare and its competitors. Blue Jet Healthcare's current Shareholder Yield % is 0.02%, which is 60% below median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blue Jet Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Blue Jet Healthcare (BOM:544009) is currently considered Fairly Valued. The stock's GF Value™ is ₹566.03, compared to a current price of ₹623.20 — trading 10.1% above its estimated fair value. The current Shareholder Yield % is 0.02%, which is 60% below median its 10-year median of 0.05. Blue Jet Healthcare's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Blue Jet Healthcare (BOM:544009), the current Shareholder Yield % is 0.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blue Jet Healthcare (BOM:544009) Overvalued in 2026?
Based on GuruFocus' analysis, Blue Jet Healthcare stock appears to be overvalued.
The current stock price of ₹623.20 is trading 10.1% above its estimated GF Value™ of ₹566.03.
GuruFocus considers Blue Jet Healthcare to be Fairly Valued.
Key valuation signals for BOM:544009:
Shareholder Yield %: 0.02% (60% below median its 10-year median of 0.05)
GF Value™: ₹566.03 vs. price of ₹623.20 (10.1% above fair value)
No single metric tells the full story. See the BOM:544009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
62GF Score
Get the complete analysis for BOM:544009
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544009 has been successfully added to your 
